
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[BSX] Boston Scientific Corp. - Financing Cash Flow / Sales
Data updated 2023-Sep-09 (Saturday)Note: Detailed Statistics for Financing Cash Flow / Sales in Cashflow Statement for Boston Scientific Corp. [NYSE:BSX] with frequency distribution chart that analyze trends & history . Financing Cash Flow / Sales or Revenue is expressed as a % for period. View Cashflow Statement for broader context
Share
Quarterly Financing Cash Flow / Sales values for Boston Scientific Corp. are rounded to enhance readability
2023-Jun | 2023-Mar | 2022-Dec | 2022-Sep | 2022-Jun | 2022-Mar | |
---|---|---|---|---|---|---|
Financing Cash Flow / Sales | 1.2% | -2.0% | 0.0% | -6.3% | -10.6% | -0.2% |
Sequential Quarter Growth | +158.3% | -6,900.0% | +100.5% | +40.8% | -5,200.0% | +23.1% |
Quarter-on Quarter Growth | +111.2% | -920.0% | +111.5% | -3,240.0% | -17,766.7% | +94.2% |
Annual Financing Cash Flow / Sales values for Boston Scientific Corp. are rounded to enhance readability
2022-Dec | 2021-Dec | 2021-Jan | 2020-Jan | 2019-Jan | 2018-Jan | |
---|---|---|---|---|---|---|
Financing Cash Flow / Sales | -4.3% | -0.8% | -0.8% | 3.0% | 27.7% | 14.6% |
Year-on-Year Growth | -476.0% | +6.3% | -127.0% | -89.3% | +89.9% | +739.5% |
2-yr CAGR | -54.9% | -9.2% | ||||
3-yr CAGR | +16.1% | |||||
4-yr CAGR | -36.0% | |||||
5-yr CAGR |
Frequency distribution of quarterly Financing Cash Flow / Sales values from 2015-Sep-30 grouped into buckets. Latest Financing Cash Flow / Sales value is 1.19 as of 2023-Jun-30
Subsequent stock performance post earnings date till next announcement for Boston Scientific Corp. mapped with quarterly Financing Cash Flow / Sales values reported at that time. Most recent value denoted with star
Select frequency and calculation type for Financing Cash Flow / Sales above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for Boston Scientific Corp. with subsequent post-earnings performance given Financing Cash Flow / Sales values. Analysis uses quarterly data and subsequent relative performance benchmarked to S&P 500 index. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
Underperform (relative perf.) | Outperform (relative perf.) | |
---|---|---|
Financing Cash Flow / Sales - Low | 56% | 44% |
Financing Cash Flow / Sales - Medium | 62% | 38% |
Financing Cash Flow / Sales - High | 42% | 58% |
Financing Cash Flow / Sales (Sequential growth %) - Low | 71% | 29% |
Financing Cash Flow / Sales (Sequential growth %) - Medium | 52% | 48% |
Financing Cash Flow / Sales (Sequential growth %) - High | 42% | 58% |
Financing Cash Flow / Sales (QoQ growth %) - Low | 35% | 65% |
Financing Cash Flow / Sales (QoQ growth %) - Medium | 68% | 32% |
Financing Cash Flow / Sales (QoQ growth %) - High | 57% | 43% |
Related to Boston Scientific Corp.
Information for Boston Scientific Corp.
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-15 on Google
SEC Reports : Quarterly reports around 2025-May-15 on SEC Edgar
Compare Boston Scientific Corp. with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Boston Scientific Corp.
Industry : Equipment & Supplies industry performance which includes Boston Scientific Corp.